Racial/Ethnic Differences in the Use and Discontinuation of Adjuvant Endocrine Therapy by Hormone-Receptor Status in Association with Mortality among Breast Cancer Patients Enrolled in Medicare Part D
Conclusions: Over two-third of patients with hormone receptor-positive breast cancer initiated AET and a substantial proportion of hormone receptor-negative women did as well. Discontinuation of AET was associated with a significantly higher risk of all-cause mortality regardless of hormone status and stage.
Source: Cancer Epidemiology Biomarkers and Prevention - Category: Cancer & Oncology Authors: Farias, A., Du, X. Tags: ASPO 41st Annual Meeting Abstracts Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Endocrine Therapy | Epidemiology | Hormones | Medicare | Study | Tamoxifen | Women